e-Therapeutics (ETX)

Advertisement

Just one of over 6000 shares you can deal on with IG. Find out more by getting your free guide to spread betting on shares. Losses can exceed your initial deposit

35.50p
   
  • Change Today:
    -0.50p
  • 52 Week High: 40.50
  • 52 Week Low: 24.75
  • Currency: UK Pounds
  • Shares Issued: 263.58m
  • Volume: 13,677
  • Market Cap: £93.57m
  • Beta: 0.17

e-Therapeutics Overview

e-Therapeutics is in the pharmaceuticals & biotechnology sector and is currently trading at 35.50p per share. In the last year e-Therapeutics's share price has ranged from 24.75p to 40.50p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart (22-05-2013)

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 8.8  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

e-Therapeutics Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Jan-09 0.07 (1.96) (2.76)p n/a n/a n/a n/a 0.0%
31-Jan-10 n/a (2.26) (2.96)p n/a n/a n/a n/a 0.0%
31-Jan-11 n/a (2.65) (3.51)p n/a n/a n/a n/a 0.0%
31-Jan-12 n/a (3.86) (2.47)p n/a n/a n/a n/a 0.0%
31-Jan-13 n/a (5.02) (3.02)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

e-Therapeutics Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Jan-14 n/a (7.65) (2.52)p n/a n/a n/a n/a 0.0%
31-Jan-15 n/a (8.95) (2.92)p n/a n/a n/a n/a 0.0%

Copyright © 2013 FactSet Research Systems Inc. All rights reserved.

e-Therapeutics Company Announcements

Preliminary results for the year ended 31 Januar... 14-May-2013 07:00 Business Wire
Notice of Results 18-Apr-2013 07:00 RNS
Director/PDMR Shareholding 04-Apr-2013 17:18 RNS

e-Therapeutics ShareCast News

e-Therapeutics pleases with pipeline progress 14-May-2013 ShareCast
Tuesday broker round-up UPDATE 14-May-2013 ShareCast
Friday broker round-up UPDATE 10-May-2013 ShareCast

Latest e-Therapeutics Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

e-Therapeutics Market Data

Currency UK Pounds
Share Price 35.50p
Change Today -0.50p
% Change -1.39 %
52 Week High 40.50
52 Week Low 24.75
Volume 13,677
Shares Issued 263.58m
Market Cap £93.57m
Beta 0.17

e-Therapeutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
57% below the market average57% below the market average57% below the market average57% below the market average57% below the market average
39.13% below the sector average39.13% below the sector average39.13% below the sector average39.13% below the sector average39.13% below the sector average
Price Trend
19.59% below the market average19.59% below the market average19.59% below the market average19.59% below the market average19.59% below the market average
24% below the sector average24% below the sector average24% below the sector average24% below the sector average24% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

e-Therapeutics Dividends

No dividends found

Trades for 22-May-2013

Time Volume / Share Price
11:04 2,000 @ 35.01p
10:00 11,677 @ 35.20p

e-Therapeutics Key Personnel

CEO Malcolm Young
CFO Daniel Elger

Top of Page